Real-life experiences with omalizumab for the treatment of chronic urticaria
Open Access
- 1 February 2014
- journal article
- research article
- Published by Elsevier BV in Annals of Allergy, Asthma & Immunology
- Vol. 112 (2), 170-174
- https://doi.org/10.1016/j.anai.2013.12.005
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Treatment of Chronic Spontaneous UrticariaAllergy, Asthma & Immunology Research, 2012
- Chronic idiopathic urticaria and anxiety symptomsJournal of Health Psychology, 2011
- Omalizumab - an effective and safe treatment of therapy-resistant chronic spontaneous urticariaAllergy, 2010
- Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumabJournal of Allergy and Clinical Immunology, 2010
- EAACI/GA²LEN/EDF/WAO guideline: management of urticariaAllergy, 2009
- EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticariaAllergy, 2009
- BSACI guidelines for the management of chronic urticaria and angio‐oedemaClinical and Experimental Allergy, 2007
- Oral Corticosteroids in Asthma: A Review of Benefits and RisksCanadian Respiratory Journal, 2007
- Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patientsAllergy, 2004
- Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticariaJournal of the American Academy of Dermatology, 2000